Skip to content

Erythromycin lactobionate

Erythrocin (erythromycin lactobionate) is a small molecule pharmaceutical. Erythromycin lactobionate was first approved as Erythrocin on 1982-01-01. It is used to treat acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, and chancroid amongst others in the USA. It is known to target motilin receptor.
Trade Name Erythrocin
Common Name Erythromycin lactobionate
Indication acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, chancroid, chlamydia infections, erythrasma, gastroenteritis, gonorrhea, legionnaires' disease, mycoplasma infections, protozoan infections, staphylococcal infections, streptococcal infections, syphilis, urethritis, whooping cough
Drug Class Antibiotics (Streptomyces strains)
Erythromycin lactobionate
Get full access now